A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma

NCT01569919 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Malignant
Pleural
Mesothelioma

Interventions

BIOLOGICAL: TroVax®
DRUG: Pemetrexed
DRUG: Cisplatin
DIETARY_SUPPLEMENT: Vitamin B12
DIETARY_SUPPLEMENT: Folic Acid
DRUG: Dexamethasone

Sponsor

Wales Cancer Trials Unit

Collaborators

[object Object]
[object Object]
[object Object]